Date Action Amount Person Type
Mar 17, 2033 Buy 410 000 Lee Phillip E Stock Option (right to buy)
Mar 28, 2024 Sell 3 902 Tucker Sean Common Stock
Mar 28, 2024 Sell 3 292 Cummings James F. Common Stock
Mar 18, 2024 Buy 90 000 Tucker Sean Common Stock
Mar 18, 2024 Buy 410 000 Tucker Sean Stock Option (right to buy)
Mar 18, 2024 Buy 410 000 Lee Phillip E Stock Option (right to buy)
Mar 18, 2024 Buy 90 000 Lee Phillip E Common Stock
Mar 18, 2024 Buy 410 000 Cummings James F. Stock Option (right to buy)
Mar 18, 2024 Buy 90 000 Cummings James F. Common Stock
Mar 18, 2024 Buy 410 000 Berg Edward B Stock Option (right to buy)
Mar 18, 2024 Buy 90 000 Berg Edward B Common Stock
Mar 18, 2024 Buy 1 000 000 Lo Steven Stock Option (right to buy)
Mar 18, 2024 Buy 250 000 Lo Steven Common Stock
Mar 18, 2024 Buy 0 Lo Steven Common Stock
Feb 02, 2024 Sell 9 220 Tucker Sean Common Stock
Feb 02, 2024 Sell 7 965 Cummings James F. Common Stock
Feb 02, 2024 Sell 9 220 Berg Edward B Common Stock
Dec 15, 2023 Sell 5 943 Lee Phillip E Common Stock
Dec 08, 2023 Sell 34 288 Tucker Sean Common Stock
Dec 08, 2023 Sell 35 151 Lee Phillip E Common Stock
Dec 08, 2023 Sell 31 409 Cummings James F. Common Stock
Dec 08, 2023 Sell 33 752 Berg Edward B Common Stock
Jun 26, 2023 Buy 44 224 Watson W. Mark Stock Option (right to buy)
Jun 26, 2023 Buy 7 375 Watson W. Mark Common Stock
Jun 26, 2023 Buy 41 510 Heron Elaine J Stock Option (right to buy)
Jun 26, 2023 Buy 6 922 Heron Elaine J Common Stock
Jun 26, 2023 Buy 44 224 Yedid Robert A. Stock Option (right to buy)
Jun 26, 2023 Buy 7 375 Yedid Robert A. Common Stock
Jun 26, 2023 Buy 44 224 Wheadon David E. Stock Option (right to buy)
Jun 26, 2023 Buy 7 375 Wheadon David E. Common Stock
Jun 26, 2023 Buy 7 375 Finney Michael J. Common Stock
Jun 26, 2023 Buy 44 224 Finney Michael J. Stock Option (right to buy)
Jun 12, 2023 Buy 22 500 Lee Phillip E Common Stock
Jun 12, 2023 Buy 102 500 Lee Phillip E Stock Option (right to buy)
Mar 28, 2023 Buy 0 Tucker Sean
Mar 28, 2023 Sell 3 683 Tucker Sean Common Stock
Mar 17, 2023 Buy 205 000 Lee Phillip E Stock Option (right to buy)
Mar 17, 2023 Buy 56 652 Lee Phillip E Common Stock
Mar 17, 2023 Buy 45 000 Lee Phillip E Common Stock
Mar 17, 2023 Buy 750 000 Floroiu Cezar Andrei Stock Option (right to buy)
Mar 17, 2023 Buy 175 000 Floroiu Cezar Andrei Common Stock
Mar 17, 2023 Buy 400 000 Floroiu Cezar Andrei Stock Option (right to buy)
Mar 17, 2023 Buy 92 735 Floroiu Cezar Andrei Common Stock
Mar 17, 2023 Buy 100 000 Floroiu Cezar Andrei Common Stock
Mar 17, 2023 Buy 410 000 Berg Edward B Stock Option (right to buy)
Mar 17, 2023 Buy 205 000 Berg Edward B Stock Option (right to buy)
Mar 17, 2023 Buy 90 000 Berg Edward B Common Stock
Mar 17, 2023 Buy 52 606 Berg Edward B Common Stock
Mar 17, 2023 Buy 45 000 Berg Edward B Common Stock
Mar 17, 2023 Buy 90 000 Lee Phillip E Common Stock
Mar 17, 2023 Buy 205 000 Lee Phillip E Stock Option (right to buy)
Mar 17, 2023 Buy 56 652 Lee Phillip E Common Stock
Mar 17, 2023 Buy 45 000 Lee Phillip E Common Stock
Mar 17, 2023 Buy 410 000 Tucker Sean Stock Option (right to buy)
Mar 17, 2023 Buy 90 000 Tucker Sean Common Stock
Mar 17, 2023 Buy 54 157 Tucker Sean Common Stock
Mar 17, 2023 Buy 205 000 Tucker Sean Stock Option (right to buy)
Mar 17, 2023 Buy 45 000 Tucker Sean Common Stock
Mar 17, 2023 Buy 410 000 Cummings James F. Stock Option (right to buy)
Mar 17, 2023 Buy 90 000 Cummings James F. Common Stock
Mar 17, 2023 Buy 205 000 Cummings James F. Stock Option (right to buy)
Mar 17, 2023 Buy 59 350 Cummings James F. Common Stock
Mar 17, 2023 Buy 45 000 Cummings James F. Common Stock
Dec 28, 2022 Buy 20 000 Watson W. Mark Common Stock
Dec 16, 2022 Buy 412 500 Lee Phillip E Stock Option (Right to Buy)
Dec 16, 2022 Buy 68 750 Lee Phillip E Common Stock
Dec 15, 2022 Buy 0 Lee Phillip E
Dec 15, 2022 Buy 0 Lee Phillip E
Aug 25, 2022 Buy 88 448 Heron Elaine J Stock Option (right to buy)
Aug 25, 2022 Buy 88 448 Heron Elaine J Stock Option (right to buy)
Aug 25, 2022 Buy 14 750 Heron Elaine J Common Stock
Aug 25, 2022 Buy 0 Heron Elaine J Common Stock
Aug 24, 2022 Sell 18 240 Yedid Robert A. Common Stock
Aug 24, 2022 Sell 4 000 Yedid Robert A. Common Stock
Aug 24, 2022 Sell 4 000 Yedid Robert A. Common Stock
Aug 19, 2022 Sell 8 000 Yedid Robert A. Stock Option (right to buy)
Aug 19, 2022 Sell 8 000 Yedid Robert A. Stock Option (right to buy)
Aug 19, 2022 Buy 8 000 Yedid Robert A. Common Stock
Aug 19, 2022 Buy 18 240 Yedid Robert A. Common Stock
Aug 19, 2022 Sell 18 240 Yedid Robert A. Stock Option (right to buy)
Aug 04, 2022 Buy 88 448 Watson W. Mark Stock Option (right to buy)
Aug 04, 2022 Buy 44 224 Yedid Robert A. Stock Option (right to buy)
Aug 04, 2022 Buy 7 375 Yedid Robert A. Common Stock
Aug 04, 2022 Buy 44 224 Wheadon David E. Stock Option (right to buy)
Aug 04, 2022 Buy 44 224 Finney Michael J. Stock Option (right to buy)
Aug 04, 2022 Buy 7 375 Davis Todd C Common Stock
Aug 04, 2022 Buy 44 224 Davis Todd C Stock Option (right to buy)
Aug 04, 2022 Buy 44 224 Davis Todd C Stock Option (right to buy)
Aug 04, 2022 Buy 37 280 Cherrington Julie M Stock Option (right to buy)
Aug 04, 2022 Buy 6 217 Cherrington Julie M Common Stock
Jun 22, 2022 Buy 5 000 Ahmad Fuad Common Stock
May 11, 2022 Buy 0 Ahmad Fuad
Apr 22, 2022 Buy 40 000 Tucker Sean Common Stock
Apr 22, 2022 Sell 40 000 Tucker Sean Stock Option (right to buy)
Mar 28, 2022 Buy 43 750 Cummings James F. Common Stock
Mar 28, 2022 Buy 550 000 Floroiu Cezar Andrei Stock Option (right to buy)
Mar 28, 2022 Buy 550 000 Floroiu Cezar Andrei Stock Option (right to buy)
Mar 28, 2022 Buy 85 000 Floroiu Cezar Andrei Common Stock
Mar 28, 2022 Buy 262 500 Tucker Sean Stock Option (right to buy)
Jan 10, 2022 Sell 1 500 Yedid Robert A. Common Stock
INSIDER POWER
511.271
Last 100 transactions
Buy: 11 300 181 | Sell: 279 805 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 511.271.

In total, the insiders bought 11 300 181 and sold 279 805 VXRT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Vaxart

Vaxart Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t... VXRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT